← Open Payments lookup

LAURA HARSH: Open Payments

NPI 1225326184 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,349 in 53 payments from 28 companies in 2025. Trend: 2023 $1,506 · 2024 $1,611 · 2025 $1,349

Food & beverage: $1,349
CompanyPaymentsAmount
Janssen Biotech, Inc.6$137
E.R. Squibb & Sons, L.L.C.4$125
Novartis Pharmaceuticals Corporation4$108
Incyte Corporation4$104
AstraZeneca Pharmaceuticals LP4$97
Astellas Pharma US Inc3$68
GENZYME CORPORATION2$62
Merck Sharp & Dohme LLC2$61
GlaxoSmithKline, LLC.2$52
Genentech USA, Inc.2$46

Products named: OPDIVO, SARCLISA, KEYTRUDA, MONJUVI, KISQALI, TALVEY, RYBREVANT, JAKAFI.

Industry payments across NV — which companies pay providers there.